SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Chelsea Therapeutics, Inc. Release: Combined Northera™ (droxidopa) Data From Two Phase 3 Trials Confirm Symptom Improvement in Patients With Neurogenic OH